期刊文献+

胰岛素每日两次治疗与强化治疗对成人隐匿性自身免疫糖尿病胰岛功能的保护作用 被引量:8

下载PDF
导出
摘要 目的探讨胰岛素每日两次治疗与强化治疗对成人隐匿性自身免疫糖尿病(LADA)患者胰岛功能的保护作用。方法 56例LADA患者随机分为A、B两组各28例,A组采用胰岛素强化治疗,B组每日两次胰岛素治疗,治疗3年测定其空腹血糖(FBG)、餐后2 h血糖(2hPG)、HbA1C、空腹C肽(FCP)。结果治疗3年两组完成随访观察各24例,其FBG、2hPG、HbA1C、FCP比较差异无统计学意义(P均>0.05)。结论胰岛素每日两次注射治疗与强化治疗LADA患者具有相同的保护胰岛功能的作用,但胰岛素每日两次注射方法简便,易被患者接受。
出处 《山东医药》 CAS 2012年第25期65-66,共2页 Shandong Medical Journal
  • 相关文献

参考文献6

  • 1Tuomi T, Groop LC, Zimmet PZ, et al. Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a non insulin dependent onset of disease[J]. Diabetes, 1993, 42 ( 3 ) :359-362.
  • 2Tumer R, Stratton Z, Horton V, et al. UKPDS 25 : autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes [ J ]. Lancet, 1997,350 (5) :1288-1293.
  • 3杨琳,周智广,黄干,颜湘,欧阳玲莉,伍汉文.LADA患者胰岛β细胞功能的前瞻性研究[J].中华内分泌代谢杂志,2003,19(4):263-266. 被引量:30
  • 4Niskanen LK, Groop LC, Tuomi T, et al. GAD autibodies in NID- DM. Ten-year follow-up from the diagnosis [ J ]. Diabetes Care, 1995,18(7) :1557-1565.
  • 5Beales PE, Pozzilli P. Thiazolidinediones for the prevention of dia- betes in the non-obese diabetic ( NOD ) mouse implications forhum- man typel diabetes [ J ]. Diabetes Metab Res, 2002,18 ( 3 ) : 114- 117.
  • 6李霞,周智广,黄干,陈小燕,颜湘,杨琳,王建平.罗格列酮对低滴度谷氨酸脱羧酶抗体的LADA患者胰岛β细胞功能的影响[J].中华内分泌代谢杂志,2004,20(6):564-567. 被引量:9

二级参考文献16

  • 1王建民,周智广,文建新,伍汉文,ThomasDyrberg.谷氨酸脱羧酶(GAD_(65))自身抗体的放射配体检测法[J].中国糖尿病杂志,1997,5(2):85-88. 被引量:21
  • 2Tuomi T, Groop LC, Zimmet PZ, et al. Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a non-insulin-dependent onset of disease. Diabetes, 1993,42:359-362.
  • 3Torn C, Landin-Olsson M, Lernmark A, et al. Prognostic factors for the course of β cell function in autoimmune diabetes. J Clin Endocrinol Metab, 2000,85:4619-4623.
  • 4Gottsater A, Landin-Olsson M, Lernmark A, et al. Glutamate decarboxylase antibody level predicts rate of beta-cell decline in adult-onset diabetes. Diabetes Res Clin Pract, 1995,27:133-140.
  • 5Gardner SG, Gale EA, Williams AJ, et al. Progression to diabetes in relatives with islet autoantibdies. Is it inevitable? Diabetes Care, 1999,22:2049-2054.
  • 6Yu L, Gianani R, Eisenbarth GS. Quantitation of glutamic acid decarboxylase autoantibody levels in prospectively evaluated relatives of patients with type 1 diabetes. Diabetes, 1994,43:1229-1233.
  • 7Turner R, Stratton I, Horton V, et al. UKPDS25 autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes. Lancet, 1997,350:1288-1293.
  • 8Li H, Isomaa B, Taskinen MR, et al. Consequences of a family history of type 1 and type 2 diabetes on the phenotype of patients with type 2 diabetes. Diabetes Care, 2000,23:589-594.
  • 9Montana E, Fernandez-Castaner M, Rosel P, et al. Age, sex and ICA influence on beta-cell secretion during the first year after the diagnosis of type 1 diabetes mellitus. Diabete Metab, 1991,17:460-468.
  • 10Kobayashi T, Nakanishi K, Sugimoto T, et al. Maleness as risk factor for slowly progressive IDDM. Diabetes Care, 1989,12:7-11.

共引文献35

同被引文献83

  • 1李光伟,宁光,周智广.2型糖尿病早期胰岛素强化治疗改善胰岛β细胞功能——是现实还是梦想?[J].中华内分泌代谢杂志,2006,22(4):309-312. 被引量:223
  • 2李延兵,朱大龙,田浩明,时立新,罗佐杰,严励,曾龙驿,周智广,杨立勇,刘娟,李明,翁建平.新诊断2型糖尿病患者β细胞功能分析[J].中华医学杂志,2006,86(36):2537-2541. 被引量:28
  • 3Khutsoane D, Shanna SK, Almustafa M, et al. Biphasic insulin aspart 30 treatment improves glycaemic control in patient with type 2 diabe- tes in a clinical practice setting: experience from the PRESENT study [ J ]. Diabetes Obes Metab ,2008,10 ( 3 ) :212 - 222.
  • 4Las G, Shirihai OS. The role of autophagy in B-cell lipotoxicity and type 2 diabetes [ J]. Diabetes Obes Metab, 2010, 12 Suppl 2:15 -19.
  • 5Cheng AY,Leiter LA. Glucose lowering and cardiovascular disease: what do we know and what should we do? [ J ]. Eur J Cardiovasc Prev Rehabil,2010,17 Suppl 1 :$25 -31.
  • 6Awad H,Alghadir A.Validation of the comprehensive international classification of functioning,disability and health core set for diabetes mellitus:Physical therapists'perspectives[J].American Journal of Physical Medicine and Rehabilitation,2013,92(11):968-979.
  • 7Chenjie Yi,Jung-Hyun Lee,et al.Diagnosis of diabetes mellitus using sialic acid expression of erythrocyte and a microfluidic resistive temperature detector(micro-RTD)[J].Sensors and Actuators,B.Chemical,2014,191:305-312.
  • 8Subhojit Ghosh,S.Maka.A constrained sub-optimal controller for glucose regulation in type 1diabetes mellitus[J].Optimal Control Applications and Methods,2014,35(2):191-203.
  • 9Erdim Sertoglu,Ismail Kurt,Serkan Tapan,et al.Comparison of plasma and erythrocyte membrane fatty acid compositions in patients with end-stage renal disease and type 2diabetes mellitus[J].Chemistry and Physics of Lipids,2014,178:11.
  • 10许雯,翁建平.新诊断2型糖尿病患者与胰岛素强化治疗[J].新医学,2008,39(7):425-428. 被引量:14

引证文献8

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部